References
- Furchgott RF, Zawadski JV. The obligatory role of endothelial cell in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–376
- Hickey KA, Rubanyi GM, Paul RJ, Higsmith RF. Characterization of a coronary vasoconstrictor produced by endothelial cells in culture. Am J Physiol. 1985;248:500–556
- Hirst DG, Robson T. Nitric oxide physiology and pathology. Methods Mol Biol. 2011;704:1–13
- Derentowicz P, Markiewicz K, Wawrzyniak M, Czerwińska-Kartowicz I, Buława E, Siwińska-Gołebiowska H. Nitric oxide (NO) – Nobel prize in medicine and physiology for 1998. Med Wieku Rozwoj. 2000;4:209–217
- Carracedo J, Buendía P, Merino A, et al. Cellular senescence determines endothelial cell damage induced by uremia. Exp Gerontol. 2013;48:766–773
- Meenakshi SR, Agarwal R. Nitric oxide levels in patients with chronic renal disease. J Clin Diagn Res. 2013;7:1288–1290
- Brunini TM, Moss MB, Siqueira MA, Santos SF, Lugon JR, Mendes-Ribeiro AC. Nitric oxide, malnutrition and chronic renal failure. Cardiovasc Hematol Agents Med Chem. 2007;5:155–161
- de Leeuw PW. Pathophysiology of hypertension in patients in renal replacement therapy. Blood Purif. 1994;12:245–251
- Davies DL, Schalekamp MA, Beevers DG, et al. Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure. Lancet. 1973;1:683–686
- Campigano JL, Ramirez-Muzo O, Ramirez-Gonzales R. Normal renin uremic hypertension: study of cardiac hemodynamics, plasma volume, extracellular fluid volume, and the renin-angiotensin system. Arch Intern Med. 1976;136:17–23
- Tuckman J, Benninger JL, Reubi F. Hemodynamics and blood volume studies in long-term hemodialysis patients and in patients with successfully transplanted kidneys. Clin Sci Mod Med. 1973;45:155–157
- Lightfoot BO, Caruana RJ. Endothelin-1 in continuous ambulatory peritoneal dialysis and hemodialysis patients: a preliminary study. Perit Dial Int. 1993;13:55–58
- Reyes AA, Karl IE, Klahr S. Role of arginine in health and in renal disease. Am J Physiol. 1994;267:331–346
- Leone A, Moncada S, Vallance P, Calver A, Collier J. Acumulation of an endogenus inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572–575
- Schmidt RJ, Baylis C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int. 2000;58:1261–1266
- Hand MF, Haynes WG, Webb DJ. Hemodialysis and L arginin but not D arginin correct renal faliure associated endothelial dysfunction. Kidney Int. 1998;53:1068–1077
- Kari JA, Donald AE, Vallance DT, et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 1997;52:468–472
- Morris ST, McMurray J, Rodger R, Jardine AG. Impaired endothelinum-dependent vazodilatation in uremia. Nephron Dial Transplant. 2000;15:572–575
- Madore F, Prudhomme L, Austin JS, et al. Impact nitric oxide in blood pressure in hemodialysis patients. Am Kidney Dis. 1997;30:665–671
- Potter GS, Johnson RJ, Fink GD. Role of endothelin in hypertension of experimental chronic renal failure. Hypertension. 1997;30:1578–1584
- Devenport A, Fernando RL, Varghese Z. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritoneal dialysis. Blood Purif. 2004;22:216–223
- Davenport A, Fernando RL, Robson R, Varghese Z. Nitric oxide production by human peritoneal mesothelial cells. Int J Artif Organs. 2004;27:15–23
- Noris M, Benigni A, Boccardo P, et al. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int. 1993;44:445–450
- Su YJ, Liao SC, Cheng BC, Hwang JC, Chen JB. Increasing high-sensitive C-reactive protein level predicts peritonitis risk in chronic peritoneal dialysis patients. BMC Nephrol. 2013;14:185
- Imai Y, Abe K, Otsuka Y, et al. Blood pressure regulation in chronic hypotensive and hypertensive patients with chronic renal failure. Jap Circ J. 1981;45:303–314
- Bussemaker E, Passauer J, Reimann D, Schulze B, Reichel W, Gross P. The vascular endothelin system is not overactive in normotensive hemodialysis patients. Kidney Int. 2002;62:940–948
- Kang DH, Yoon KI, Han DS. Acute effects of recombinant human erythropoietin on plasma levels of proendothelin-1 and endothelin-1 in hemodialysis patients. Nephrol Dial Transplant. 1998;13:2877–2883
- Lebel M, Moreau V, Grose JH, Kingma I, Langlois S. Plasma and peritoneal endothelin levels and blood pressure in CAPD patients with or without erythropoietin replacement therapy. Clin Nephrol. 1998;49:313–318
- Kourti P, Zarogiannis SG, Liakopoulos V, et al. Endothelin-1 acutely reduces the permeability of visceral sheep peritoneum in vitro through both endothelin-A and endothelin-B receptors. Artif Organs. 2013;37:308–312
- Kourti P, Zarogiannis S, Liakopoulos V, et al. Effect of endothelin-1 on the transmesothelial resistance of isolated visceral sheep peritoneum. Adv Perit Dial. 2007;23:38–42
- Morgera S, Kuchinke S, Budde K, Lun A, Hocher B, Neumayer HH. Volume stress-induced peritoneal endothelin-1 release in continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1999;10:2585–2590